Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7293-7301
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7293
Table 4 Comparison of general clinical data of pathological complete remission and non-pathological complete remission patients, n (%)
General clinical data
pCR
Non-pCR
t/χ2 value
P value
Cases2070
Age (yr)49.02 ± 8.1951.02 ± 9.92-0.8240.412
Lesion diameter (cm)4.42 ± 1.234.12 ± 1.200.9810.329
ER positive12 (60.00)41 (58.57)0.0130.909
PR positive 11 (55.00)35 (50.00)0.1560.693
Ki-67 > 14%17 (85.00)34 (48.57)8.4070.004
HER2 positive7 (35.00)12 (17.14)2.0030.157
Pathological type0.3860.534
Invasive ductal carcinoma16 (80.00)62 (88.57)
Invasive lobular carcinoma4 (20.00)8 (11.43)
Molecular subtypes2.5480.467
Triple negative3 (15.00)10 (14.29)
HER26 (30.00)23 (32.86)
Luminal B11 (55.00)30 (42.86)
Luminal A0 (0.00)7 (10.00)